Zavicefta is an antibiotic used in adults and children from birth to treat the following infections: - complicated (difficult to treat) infections of the tissues and organs in the belly (intra-abdominal infections); - complicated infections of the urinary tract, including pyelonephritis (kidney infection); - infections of the lungs caught in hospital (hospital-acquired pneumonia), including ventilator-associated pneumonia (pneumonia caught from a ventilator, a machine that helps a patient to breathe). Zavicefta can be used in adults and children from birth for infections caused by aerobic Gram-negative bacteria (types of bacteria) when other treatments might not work. Zavicefta can also be used in adults for infections of the blood (bacteraemia) associated with any of the above infections. Zavicefta contains the active substances ceftazidime and avibactam.
Therapeutic Indication
### Therapeutic indication Zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections: - Complicated intra-abdominal infection (cIAI) - Complicated urinary tract infection (cUTI), including pyelonephritis - Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP) Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Zavicefta is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Therapeutic Area (MeSH)
N/AATC Code
J01DD52
ATC Item
ceftazidime and beta-lactamase inhibitor
Pharmacotherapeutic Group
Antibacterials for systemic use
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Zavicefta
Medicine Name
Zavicefta
Aliases
N/ANo risk management plan link.
